Comparative study between coral-mesenchymal stem cells-rhBMP-2 composite and auto-bone-graft in rabbit critical-sized cranial defect model.

Tissue engineered bone has become a bone substitute for the treatment of bone defects in animal research. This study investigated the osteogenesis capacity of coral-MSCs-rhBMP-2 composite with the auto-bone-graft as control. Coral-MSCs-rhBMP-2 composite were fabricated by coral (as main scaffold), rhBMP-2 (as growth factor), and MSCs (cultured from iliac marrow as seed cells). Critical-sized defects (d = 15 mm) were made on forty rabbits crania and treated by different composite scaffolds: iliac autograft (n = 8), coral (n = 8), rhBMP-2/coral (n = 8), and MSCs/rhBMP-2/coral (n = 8). The defects were evaluated by gross observation, radiographic examination, histological examination, and histological fluorescence examinations after 8 and 16 weeks. The results showed that repair of bone defect was the least in coral group, and significant ingrowth of new bone formation and incorporation could be seen with 77.45% +/- 0.52% in radiopacity in MSCs/rhBMP-2/coral group, which was similar to that in iliac autograft group (84.61% +/- 0.56% in radiopacity). New bone formation in MSCs/rhBMP-2/coral group was more than that in rhBMP-2/coral group. And osteogenesis rate in MSCs/rhBMP-2/coral group (10.23 +/- 1.45 microm) was much faster than that in rhBMP-2/coral group (5.85 +/- 2.19 microm) according to histological fluorescence examination. Newly formed bone partly came from induced MSCs in composite scaffold according to bromodeoxyuridine immunohistochemical examination. These data implicated that MSCs could produce synergic effect with coral-rhBMP-2, and the tissue engineered bone of coral-MSCs-rhBMP-2 is comparable to auto-bone-graft for the repair of critical-sized bone defect.

[1]  L Sedel,et al.  Osteogenesis with coral is increased by BMP and BMC in a rat cranioplasty. , 1999, Biomaterials.

[2]  F. Melsen,et al.  Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. , 1995, Bone.

[3]  E. Barboza,et al.  Potential of recombinant human bone morphogenetic protein-2 in bone regeneration. , 1999, Implant dentistry.

[4]  O. Cornu,et al.  Bone substitutes in 2003: an overview. , 2003, Acta orthopaedica Belgica.

[5]  Freddie H. Fu,et al.  Effect of Bone Morphogenetic Protein-2-Expressing Muscle-Derived Cells on Healing of Critical-Sized Bone Defects in Mice , 2001, The Journal of bone and joint surgery. American volume.

[6]  G. Sándor,et al.  Closure of Critical Sized Defects With Allogenic and Alloplastic Bone Substitutes , 2002, The Journal of craniofacial surgery.

[7]  M. Randolph.  Tissue Engineered Bone Repair of Calvarial Defects Using Cultured Periosteal Cells , 1998 .

[8]  E. Schepers,et al.  Bone healing in porous implants: a histological and histometrical comparative study on sheep , 2000, Journal of materials science. Materials in medicine.

[9]  Jason A Burdick,et al.  An initial investigation of photocurable three-dimensional lactic acid based scaffolds in a critical-sized cranial defect. , 2003, Biomaterials.

[10]  C. V. van Blitterswijk,et al.  Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat , 2004, Journal of Orthopaedic Research.

[11]  S. Goldstein,et al.  Marrow‐derived progenitor cell injections enhance new bone formation during distraction , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  J O Hollinger,et al.  Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats. , 1999, Journal of biomedical materials research.

[13]  A. Scarano,et al.  Clinical and histological results in alveolar ridge enlargement using coralline calcium carbonate. , 1997, Biomaterials.

[14]  J. Meyer,et al.  Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  Swee Hin Teoh,et al.  Repair of calvarial defects with customised tissue-engineered bone grafts II. Evaluation of cellular efficiency and efficacy in vivo. , 2003, Tissue engineering.

[16]  J. Lou,et al.  Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[17]  T. Jämsä,et al.  Native bovine bone morphogenetic protein improves the potential of biocoral to heal segmental canine ulnar defects , 2000, International Orthopaedics.

[18]  P. Jalovaara,et al.  Composite Implant of Native Bovine Bone Morphogenetic Protein (BMP) and Biocoral in the Treatment of Scaphoid Nonunions — A Preliminary Study , 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[19]  Ranieri Cancedda,et al.  Bone Marrow Stromal Cells (BMSCs) in Bone Engineering: Limitations and Recent Advances , 2004, Annals of Biomedical Engineering.

[20]  P. Jalovaara,et al.  Composite implant of native bovine bone morphogenetic protein (BMP), collagen carrier and biocoral in the treatment of resistant ulnar nonunions: report of five preliminary cases , 2003, Archives of Orthopaedic and Trauma Surgery.

[21]  Malcolm N. Cooke,et al.  Poly(propylene fumarate) and poly(DL-lactic-co-glycolic acid) as scaffold materials for solid and foam-coated composite tissue-engineered constructs for cranial reconstruction. , 2003, Tissue engineering.

[22]  J. Vacanti,et al.  The science of tissue engineering. , 2000, The Orthopedic clinics of North America.

[23]  David M. Wilson,et al.  A histomorphometric study of adaptive responses of cancellous bone in different regions in the sheep mandibular condyle following experimental forward mandibular displacement. , 2002, Archives of oral biology.

[24]  C. Brighton,et al.  The use and possible misuse of tetracycline as a vital stain. , 1979, Clinical orthopaedics and related research.

[25]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[26]  V. Rosen,et al.  The BMP proteins in bone formation and repair. , 1992, Trends in genetics : TIG.

[27]  S. Bruder,et al.  Mesenchymal stem cells in bone development, bone repair, and skeletal regenaration therapy , 1994 .

[28]  J O Hollinger,et al.  The critical size defect as an experimental model for craniomandibulofacial nonunions. , 1986, Clinical orthopaedics and related research.

[29]  Tianqiu Mao,et al.  Bone graft in the shape of human mandibular condyle reconstruction via seeding marrow-derived osteoblasts into porous coral in a nude mice model. , 2002, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[30]  S. Alexis,et al.  The fluorohydroxyapatite (FHA) FRIOS®Algipore®is a suitable biomaterial for the reconstruction of severely atrophic human maxillae , 2003, Clinical Oral Implants Research.

[31]  M. Bostrom,et al.  Biosynthetic bone grafting. , 1999, Clinical orthopaedics and related research.

[32]  Jay R Lieberman,et al.  The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.

[33]  J. Jansen,et al.  Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits. , 2004, Biomaterials.

[34]  H. Gratzner,et al.  Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. , 1982, Science.

[35]  V. Pellegrini,et al.  A comparison of the vastus splitting and median parapatellar approaches in total knee arthroplasty. , 1999, Clinical orthopaedics and related research.